This Boston-based biotech innovator in CNS disorders just reported significant insider selling amid a year of standout stock ...
PALSONIFY is the first once-daily, oral therapy approved to treat acromegaly in the European UnionApproval based on strength of data from two ...
A 12-year-old athlete prescribed a statin sparked a deeper question: are we treating numbers or people? This letter unpacks ...